Edition:
United Kingdom

People: DexCom Inc (DXCM.OQ)

DXCM.OQ on NASDAQ Stock Exchange Global Select Market

118.12USD
9:00pm BST
Change (% chg)

$-0.70 (-0.59%)
Prev Close
$118.82
Open
$119.26
Day's High
$120.01
Day's Low
$117.25
Volume
300,375
Avg. Vol
444,655
52-wk High
$156.16
52-wk Low
$72.62

Doubleday, Richard 

Mr. Richard B. Doubleday serves as Executive Vice President, Chief Commercial Officer of DexCom Inc., since January 2015. From February 2013 to January 2015, Mr. Doubleday served as our Senior Vice President of Worldwide Sales and Marketing. From June 2009 to February 2013, Mr. Doubleday served as our Vice President of Sales. From May 1988 to June 2009, Mr. Doubleday served in various roles for Johnson & Johnson, Inc. (“J&J”), including Director of Marketing for J&J subsidiary Animas Corporation, a manufacturer of insulin pumps, from July 2006 to June 2009, and Field Sales Director for J&J subsidiary LifeScan, Inc., a manufacturer of blood glucose monitoring systems, from August 2002 to October 2005. Mr. Doubleday received a B.A. from Michigan State University.

Basic Compensation

Total Annual Compensation, USD 744,354
Restricted Stock Award, USD 2,152,360
Long-Term Incentive Plans, USD --
All Other, USD 22,446
Fiscal Year Total, USD 2,919,160

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Kevin Sayer

7,924,870

Quentin Blackford

5,115,200

Donald Abbey

2,919,160

Andrew Balo

3,016,910

Richard Doubleday

2,919,160

Steven Pacelli

2,919,160
As Of  31 Dec 2017